Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 1904

The move also comes when Apple faces stiff competition from other tech giants in the electric vehicle space, such as Xiaomi and Sony.

Apple has reportedly finally given up on its long-running and secretive electric car project.

The project was dubbed Project Titan. According to a report by Bloomberg, the tech giant reportedly broke the news to its employees on Tuesday. The report said that many of the 2,000-strong car team will be reassigned to other areas, such as generative AI.

The decision to scrap the electric car project is a surprise, given that Apple has been on it for years. Reportedly it has even tested its autonomous driving technology on public roads.

Continue reading “Apple pulls the plug on its electric car project” | >

The Microsoft-Mistral agreement draws the scrutiny of the European Commission.

Microsoft has inked a multi-year partnership with French startup Mistral AI to make its artificial intelligence (AI) models, like ‘Le Chat,’ available through the Azure cloud computing platform.

Essentially, Microsoft’s investment will be used to purchase equity in Mistral. The valuation of Mistral AI remains the same even after Microsoft’s investment.

This move comes amidst regulatory scrutiny faced by Microsoft in Europe and the US over its significant investment in OpenAI.

Continue reading “Mistral AI: Microsoft invests M in OpenAI French doppelgänger” | >

One of the immune system’s primary roles is to detect and kill cells that have acquired cancerous mutations. However, some early-stage cancer cells manage to evade this surveillance and develop into more advanced tumors.

A new study from MIT and Dana-Farber Cancer Institute has identified one strategy that helps these avoid immune detection. The researchers found that early in colon cancer development, cells that turn on a gene called SOX17 can become essentially invisible to the immune system.

If scientists could find a way to block SOX17 function or the pathway that it activates, this may offer a new way to treat early-stage cancers before they grow into larger tumors, the researchers say.

Read more | >

Most cancers are thought to evade the immune system. These cancers don’t carry very many mutations, and they aren’t infiltrated by cancer-fighting immune cells. Scientists call these cancers immunologically “cold.”

Now new research suggests such cancers aren’t as “cold” as once thought. Researchers from the La Jolla Institute for Immunology (LJI), UC San Diego Moores Cancer Center, and UC San Diego, have found that patients with “cold” tumors actually do make cancer-fighting T cells.

This discovery opens the door to developing vaccines or therapies to increase T cell numbers and treat many more types of cancer than currently thought possible.

Read more | >